Cargando…
Development and optimization of orthotopic liver metastasis xenograft mouse models in uveal melanoma
BACKGROUND: Patients with metastatic uveal melanoma (MUM) in the liver usually die within 1 year. The development of new treatments for MUM has been limited by the lack of diverse MUM cell lines and appropriate animal models. We previously reported that orthotopic xenograft mouse models established...
Autores principales: | Sugase, Takahito, Lam, Bao Q., Danielson, Meggie, Terai, Mizue, Aplin, Andrew E., Gutkind, J. Silvio, Sato, Takami |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7240939/ https://www.ncbi.nlm.nih.gov/pubmed/32434572 http://dx.doi.org/10.1186/s12967-020-02377-x |
Ejemplares similares
-
Establishment of an orthotopic patient-derived xenograft mouse model using uveal melanoma hepatic metastasis
por: Kageyama, Ken, et al.
Publicado: (2017) -
Prognostic Values of G-Protein Mutations in Metastatic Uveal Melanoma
por: Terai, Mizue, et al.
Publicado: (2021) -
Stromal fibroblast growth factor 2 reduces the efficacy of bromodomain inhibitors in uveal melanoma
por: Chua, Vivian, et al.
Publicado: (2019) -
Dual Targeting of CDK4/6 and cMET in Metastatic Uveal Melanoma
por: Ohara, Masahiro, et al.
Publicado: (2021) -
The Role of HGF/MET Signaling in Metastatic Uveal Melanoma
por: Tanaka, Ryota, et al.
Publicado: (2021)